Physician profile
Joseph P Hicks
NPI 1437148616
$3,825.53
in general payments reported to CMS, 2019-2025
46 companies · $424 in 2025
The $424 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $500 · 2021: $726 · 2022: $616 · 2023: $388 · 2024: $717 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,529.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $369.55 | 2023-2025 | Gemtesa |
| Myriad Genetic Laboratories, INC. | $308.30 | 2020-2024 | Prolaris |
| Endo Pharmaceuticals INC. | $297.35 | 2019-2024 | Xiaflex |
| Allergan, INC. | $282.86 | 2019-2022 | |
| Astellas Pharma US INC | $278.29 | 2019-2024 | Myrbetriq |
| Procept Biorobotics Corporation | $171.13 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Clarus Therapeutics INC. | $160.76 | 2021 | |
| Medtronic, INC. | $156.98 | 2021-2024 | Interstim |
| Pfizer INC. | $155.07 | 2023-2025 | |
| Rochester Medical Corporation | $153.37 | 2019-2022 | |
| Coloplast Corp | $141.48 | 2019-2021 | |
| Urovant Sciences INC | $131.95 | 2022 | |
| Endo USA, INC. | $108.00 | 2024-2025 | Xiaflex |
| Boston Scientific Corporation | $106.82 | 2019-2025 | Rezum Generator, Solyx Sis System |
| Tolmar Pharmaceuticals, INC. | $104.16 | 2019-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $91.19 | 2019-2025 | Itind System, Olympus |
| Tolmar, INC. | $61.66 | 2023-2024 | |
| Antares Pharma, INC. | $58.80 | 2019-2025 | Xyosted, Tlando |
| Urogen Pharma, INC. | $55.33 | 2022-2025 | |
| Accord Healthcare, INC. | $48.91 | 2022-2024 | |
| Dendreon Pharmaceuticals LLC | $42.06 | 2022 | |
| Zyla Life Sciences, INC. | $41.63 | 2019-2020 | |
| Kerecis Limited | $37.16 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Edap Technomed INC | $36.00 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.85 | 2020-2021 | |
| Abbvie INC. | $31.04 | 2023-2024 | |
| Innovation Technologies INC | $25.00 | 2024 | Irrisept |
| Civco Medical Instruments | $24.97 | 2025 | |
| Blue Earth Diagnostics | $24.55 | 2019 | |
| Conmed Corporation | $23.66 | 2023 | Airseal |
| Hollister Incorporated | $23.37 | 2022 | |
| Agiliti Surgical, INC. | $22.18 | 2022 | |
| Janssen Biotech, INC. | $21.58 | 2025 | Erleada |
| Travere Therapeutics, INC. | $20.77 | 2019-2022 | |
| Palette Life Sciences, INC. | $19.01 | 2022 | |
| Convatec INC. | $18.26 | 2019 | |
| Integra Lifesciences Corporation | $16.43 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Laborie Medical Technologies Corp. | $15.43 | 2022 | |
| Axonics, INC. | $14.81 | 2023 | Axonics |
| Halozyme INC | $14.74 | 2023 | |
| Profound Medical Corp. | $14.41 | 2022 | |
| Hologic Sales and Service, LLC | $13.92 | 2024 | Coolseal Generator, Myosure Tissue Removal Device |
| Photocure INC | $12.93 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.13 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.94 | 2019 | |
| Medtronic USA, INC. | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.